Petra Acquisition, Inc. (PAIC) to Combine with Revelation Biosciences in $128M Deal

Petra (NASDAQ:PAIC) has entered into a definitive agreement to combine with biotech firm Revelation Biosciences at an enterprise value of $128 million. San Diego-based Revelation is developing two drug candidates aimed at treating respiratory diseases as well as a diagnostic device for diagnosing viral infections. The combined company is expected to trade on the Nasdaq
Read More